VCU’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain
To prevent domestic shortages of critical medications, the Medicines for All Institute, based in the Virginia Commonwealth University College of Engineering, has joined forces with pharmaceutical industry leaders to bring manufacturing of vulnerable pharmaceuticals and their ingredients back to the United States.
WVU Rockefeller Neuroscience Institute and Oura Health unveil study to predict the outbreak of COVID-19 in healthcare professionals
The West Virginia University Rockefeller Neuroscience Institute, WVU Medicine, and smart ring maker Oura Health today (April 8) announced a national study designed to accelerate early detection of the COVID-19 virus symptoms and contagiousness.
‘We wanted to do something to help’: VCU Engineering lab produces hand sanitizer
Hand sanitizer. Toilet paper. Disinfectant wipes. When the COVID-19 pandemic emptied store shelves of such in-demand products, Thomas D. Roper, Ph.D., figured his Virginia Commonwealth University College of Engineering lab could help with one of them: hand sanitizer.
Texas Tech University Health Sciences Center, Texas Tech University Join Forces to Develop 3D-Printed Face Masks, Shields to Fight COVID-19
A collaborative group of faculty from Texas Tech University and the Texas Tech University Health Sciences Center (TTUHSC) are joining forces to create 3D-printed face shields and face masks for health care workers in hopes of fighting the spread of the coronavirus (COVID-19).
University volunteers create face shields for health care workers
For University of Louisiana at Lafayette mechanical engineering instructor Yasmeen Qudsi, a 3-D printer, a computer-controlled “cutting plotter” and thousands of sheets of laminating paper have been essential supplies as she works remotely during the coronavirus outbreak.
Anew potential drug target has been identified in SARS CoV-2 — the virus that causes COVID-19 — by scientists at the Center of Structural Genomics of Infectious Diseases, or CSGID, who say multiple drugs will be needed to treat the pandemic.
Colorado State University has been recently active in COVID-19 research. The university has been asked by Gov. Jared Polis and the State of Colorado to lead testing qualification for protective masks in COVID-19 fight.
CU Boulder's Research & Innovation COVID-19 Impact
Faculty, staff and students from across CU Boulder are discovering and creating new and innovative ways to address the challenges posed by the COVID-19 pandemic—benefitting the university, the community, the state and the nation.
SIU makes final COVID-19 test component delivery to state after successful effort
Southern Illinois University Carbondale today will ship its final batch of a crucial COVID-19 test element to state of Illinois health officials, bringing the team’s final production tally to 115,000 vials of Viral Transport Medium.
Purdue develops application to quantify impact of COVID-19 on research programs
To measure and document the level of disruption caused by COVID-19, Purdue University and Microsoft are collaborating on a tool that allows campus researchers to input information about how specific sponsored programs have been affected.
UK Gets NSF Funding to Develop Face Mask that Can Deactivate COVID-19
University of Kentucky engineering professor Dibakar Bhattacharyya recently announced he had the concept and the means to develop a medical face mask that would capture and deactivate COVID-19 on contact.
UofL developing robot to disinfect areas with coronavirus risk
Many doctors, nurses, EMTs and other health care workers have risked infection while fighting the coronavirus pandemic. But researchers at the University of Louisville think they have a solution that could help reduce that risk.
As with many universities and communities facing the COVID-19 pandemic, Wayne State University has adjusted its research support and programs during this period to best manage the challenge at hand for the health and well-being of all.
Researchers in the Center for Translational Medicine at the University of Montana have been awarded $2.5 million in funding from the National Institutes of Health to identify and advance a COVID-19 vaccine candidate.